Retinal astrocytes respond to IL-17 differently than retinal pigment epithelial cells

Journal of Leukocyte Biology

Volumn 86, Issue 6, 2009, Pages 1377-1384

  Ke, Yan ^a   Jiang, Guomin ^a   Sun, Deming ^b   Kaplan, Henry J ^a   Shao, Hui ^a  

^a University of Louisville School of Medicine   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

Autoimmunity; Cytokines; Inflammation; Tissue cells

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 17; INTERLEUKIN 17 RECEPTOR; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; SUPPRESSOR OF CYTOKINE SIGNALING 1; SUPPRESSOR OF CYTOKINE SIGNALING 3;

ANIMAL CELL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; ASTROCYTE; CELL MIGRATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; GRANULOCYTE; MOUSE; NONHUMAN; PIGMENT EPITHELIUM; PRIORITY JOURNAL; PROTEIN EXPRESSION; RETINA CELL; SIGNAL TRANSDUCTION;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ANIMALS; ANTIVIRAL AGENTS; ASTROCYTES; CELL MOVEMENT; CHEMOKINES; EPITHELIAL CELLS; FEMALE; GENE EXPRESSION REGULATION; INFLAMMATION; INTERFERON-GAMMA; INTERLEUKIN-17; MICE; ORGAN SPECIFICITY; PROTO-ONCOGENE PROTEINS C-AKT; RETINAL PIGMENT EPITHELIUM; SIGNAL TRANSDUCTION; SUPPRESSOR OF CYTOKINE SIGNALING PROTEINS;

EID: 73149103244     PISSN: 07415400     EISSN: None     Source Type: Journal    
DOI: 10.1189/jlb.0409237     Document Type: Article

References (39)

1. Amadi-Obi, A., Yu, C. R., Liu, X., Mahdi, R. M., Clarke, G. L., Nussenblatt, R. B., Gery, I., Lee, Y. S., Egwuagu, C. E. (2007) TH17 cells contribute to uveitis and scleritis and are expanded by IL-2 and inhibited by IL-27/STAT1. Nat. Med. 13, 711-718.
2. Jiang, G., Ke, Y., Sun, D., Han, G., Kaplan, H. J., Shao, H. (2008) Reactivation of uveitogenic T cells by retinal astrocytes derived from experimental autoimmune uveitis-prone B10RIII mice. Invest. Ophthalmol. Vis. Sci. 49, 282-289.
3. Peng, Y., Han, G., Shao, H., Wang, Y., Kaplan, H. J., Sun, D. (2007) Characterization of IL-17+ interphotoreceptor retinoid-binding protein-specific T cells in experimental autoimmune uveitis. Invest. Ophthalmol. Vis. Sci. 48, 4153-4161.
4. Tang, J., Zhu, W., Silver, P. B., Su, S. B., Chan, C. C., Caspi, R. R. (2007) Autoimmune uveitis elicited with antigen-pulsed dendritic cells has a distinct clinical signature and is driven by unique effector mechanisms: initial encounter with autoantigen defines disease phenotype. J. Immunol. 178, 5578-5587.
5. Yoshimura, T., Sonoda, K. H., Miyazaki, Y., Iwakura, Y., Ishibashi, T., Yoshimura, A., Yoshida, H. (2008) Differential roles for IFN-γ and IL-17 in experimental autoimmune uveoretinitis. Int. Immunol. 20, 209-214.
6. Aggarwal, S., Gurney, A. L. (2002) IL-17: prototype member of an emerging cytokine family. J. Leukoc. Biol. 71, 1-8.
7. Gaffen, S. L. (2008) An overview of IL-17 function and signaling. Cytokine 43, 402-407.
8. Jovanovic, D. V., Di Battista, J. A., Martel-Pelletier, J., Jolicoeur, F. C., He, Y., Zhang, M., Mineau, F., Pelletier, J. P. (1998) IL-17 stimulates the production and expression of proinflammatory cytokines, IL-{β} and TNF-{α}, by human macrophages. J. Immunol. 160, 3513-3521.
9. Chabaud, M., Fossiez, F., Taupin, J. L., Miossec, P. (1998) Enhancing effect of IL-17 on IL-1-induced IL-6 and leukemia inhibitory factor production by rheumatoid arthritis synoviocytes and its regulation by Th2 cytokines. J. Immunol. 161, 409-414.
10. Hofstetter, H. H., Ibrahim, S. M., Koczan, D., Kruse, N., Weishaupt, A., Toyka, K. V., Gold, R. (2005) Therapeutic efficacy of IL-17 neutralization in murine experimental autoimmune encephalomyelitis. Cell. Immunol. 237, 123-130.
11. Koenders, M. I., Joosten, L. A., van den Berg, W. B. (2006) Potential new targets in arthritis therapy: interleukin (IL)-17 and its relation to tumor necrosis factor and IL-1 in experimental arthritis. Ann. Rheum. Dis. 65 (Suppl. 3), iii29 -iii33.
12. Ouyang, W., Kolls, J. K., Zheng, Y. (2008) The biological functions of T helper 17 cell effector cytokines in inflammation. Immunity 28, 454-467.
13. Peng, Y., Han, G., Shao, H., Wang, Y., Kaplan, H. J., Sun, D. (2007) Characterization of IL-17+ interphotoreceptor retinoid-binding proteinspecific T cells in experimental autoimmune uveitis. Invest. Ophthalmol. Vis. Sci. 48, 4153-4161.
14. Grewal, I. S., Grewal, K. D., Wong, F. S., Picarella, D. E., Janeway Jr., C. A., Flavell, R. A. (1996) Local expression of transgene encoded TNF α in islets prevents autoimmune diabetes in nonobese diabetic (NOD) mice by preventing the development of auto-reactive islet-specific T cells. J. Exp. Med. 184, 1963-1974.
15. Christen, U., Wolfe, T., Mohrle, U., Hughes, A. C., Rodrigo, E., Green, E. A., Flavell, R. A., von Herrath, M. G. (2001) A dual role for TNF-{{α}} in type 1 diabetes: islet-specific expression abrogates the ongoing autoimmune process when induced late but not early during pathogenesis. J. Immunol. 166, 7023-7032.
16. Flaishon, L., Topilski, I., Shoseyov, D., Hershkoviz, R., Fireman, E., Levo, Y., Marmor, S., Shachar, I. (2002) Cutting edge: anti-inflammatory properties of low levels of IFN-{γ}. J. Immunol. 168, 3707-3711.
17. Billiau, A., Heremans, H., Vandekerckhove, F., Dijkmans, R., Sobis, H., Meulepas, E., Carton, H. (1988) Enhancement of experimental allergic encephalomyelitis in mice by antibodies against IFN-γ. J. Immunol. 140, 1506-1510.
18. Xing, Z., Gauldie, J., Cox, G., Baumann, H., Jordana, M., Lei, X. F., Achong, M. K. (1998) IL-6 is an antiinflammatory cytokine required for controlling local or systemic acute inflammatory responses. J. Clin. Invest. 101, 311-320.
19. Ke, Y., Liu, K., Huang, G. Q., Cui, Y., Kaplan, H. J., Shao, H., Sun, D. (2009) Anti-inflammatory role of IL-17 in experimental autoimmune uveitis. J. Immunol. 182, 3183-3190.
20. Sun, D., Enzmann, V., Lei, S., Sun, S. L., Kaplan, H. J., Shao, H. (2003) Retinal pigment epithelial cells activate uveitogenic T cells when they express high levels of MHC class II molecules, but inhibit T cell activation when they express restricted levels. J. Neuroimmunol. 144, 1-8.
21. Shao, H., Lei, S., Sun, S. L., Kaplan, H. J., Sun, D. (2003) Conversion of monophasic to recurrent autoimmune disease by autoreactive T cell subsets. J. Immunol. 171, 5624-5630.
22. Sun, D., Lohmann-Matthes, M. L. (1982) Functionally different subpopulations of mouse macrophages recognized by monoclonal antibodies. Eur. J. Immunol. 12, 134-140.
23. Shao, H., Liao, T., Ke, Y., Shi, H., Kaplan, H. J., Sun, D. (2006) Severe chronic experimental autoimmune uveitis (EAU) of the C57BL/6 mouse induced by adoptive transfer of IRBP1-20-specific T cells. Exp. Eye Res. 82, 323-331.
24. Kerr, E. C., Copland, D. A., Dick, A. D., Nicholson, L. B. (2008) The dynamics of leukocyte infiltration in experimental autoimmune uveoretinitis. Prog. Retin. Eye Res. 27, 527-535.
25. Liao, T., Ke, Y., Shao, W. H., Haribabu, B., Kaplan, H. J., Sun, D., Shao, H. (2006) Blockade of the interaction of leukotriene B4 with its receptor prevents development of autoimmune uveitis. Invest. Ophthalmol. Vis. Sci. 47, 1543-1549.
26. Shi, G., Maminishkis, A., Banzon, T., Jalickee, S., Li, R., Hammer, J., Miller, S. S. (2008) Control of chemokine gradients by the retinal pigment epithelium. Invest. Ophthalmol. Vis. Sci. 49, 4620-4630.
27. Alexander, W. S. (2002) Suppressors of cytokine signaling (SOCS) in the immune system. Nat. Rev. Immunol. 2, 410-416.
28. Alexander, W. S., Starr, R., Fenner, J. E., Scott, C. L., Handman, E., Sprigg, N. S., Corbin, J. E., Cornish, A. L., Darwiche, R., Owczarek, C. M., Kay, T. W., Nicola, N. A., Hertzog, P. J., Metcalf, D., Hilton, D. J. (1999) SOCS1 is a critical inhibitor of interferon γ signaling and prevents the potentially fatal neonatal actions of this cytokine. Cell 98, 597-608.
29. Croker, B. A., Krebs, D. L., Zhang, J. G., Wormald, S., Willson, T. A., Stanley, E. G., Robb, L., Greenhalgh, C. J., Forster, I., Clausen, B. E., Nicola, N. A., Metcalf, D., Hilton, D. J., Roberts, A. W., Alexander, W. S. (2003) SOCS3 negatively regulates IL-6 signaling in vivo. Nat. Immunol. 4, 540-545.
30. Lang, R., Pauleau, A. L., Parganas, E., Takahashi, Y., Mages, J., Ihle, J. N., Rutschman, R., Murray, P. J. (2003) SOCS3 regulates the plasticity of gp130 signaling. Nat. Immunol. 4, 546-550 .
31. Yasukawa, H., Yajima, T., Duplain, H., Iwatate, M., Kido, M., Hoshijima, M., Weitzman, M. D., Nakamura, T., Woodard, S., Xiong, D., Yoshimura, A., Chien, K. R., Knowlton, K. U. (2003) The suppressor of cytokine signaling-1 (SOCS1) is a novel therapeutic target for enterovirus-induced cardiac injury. J. Clin. Invest. 111, 469-478.
32. Egwuagu, C. E., Yu, C. R., Li, Z., Nussenblatt, R. B. (2005) SOCS5 mRNA levels in peripheral blood mononuclear cells (PBMC): a potential biomarker for monitoring response of uveitis patients to Daclizumab therapy. J. Autoimmun. 24, 39-46.
33. Takase, H., Yu, C. R., Liu, X., Fujimoto, C., Gery, I., Egwuagu, C. E. (2005) Induction of suppressors of cytokine signaling (SOCS) in the retina during experimental autoimmune uveitis (EAU): potential neuroprotective role of SOCS proteins. J. Neuroimmunol. 168, 118-127.
34. Stark, J. L., Lyons, J. A., Cross, A. H. (2004) Interferon-γ produced by encephalitogenic cells induces suppressors of cytokine signaling in primary murine astrocytes. J. Neuroimmunol. 151, 195-200.
35. Turnley, A. M., Starr, R., Bartlett, P. F. (2002) Failure of sensory neurons to express class I MHC is due to differential SOCS1 expression. J. Neuroimmunol. 123, 35-40.
36. Starr, R., Willson, T. A., Viney, E. M., Murray, L. J., Rayner, J. R., Jenkins, B. J., Gonda, T. J., Alexander, W. S., Metcalf, D., Nicola, N. A., Hilton, D. J. (1997) A family of cytokine-inducible inhibitors of signaling. Nature 387, 917-921.
37. Fujimoto, M., Naka, T. (2003) Regulation of cytokine signaling by SOCS family molecules. Trends Immunol. 24, 659-666.
38. Dalpke, A. H., Opper, S., Zimmermann, S., Heeg, K. (2001) Suppressors of cytokine signaling (SOCS)-1 and SOCS-3 are induced by CpG-DNA and modulate cytokine responses in APCs. J. Immunol. 166, 7082-7089.
39. Crespo, A., Filla, M. B., Murphy, W. J. (2002) Low responsiveness to IFN-γ, after pretreatment of mouse macrophages with lipopolysaccharides, develops via diverse regulatory pathways. Eur. J. Immunol. 32, 710-719.